Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a new study.

A newly identified subtype of Castleman disease will help diagnose and properly treat thousands of patients who have been ...

This study presents a valuable finding on the direct cytotoxic effects of DuoHexaBody-CD37 in diffuse large B-cell lymphoma, mediated via SHP-1 activation and antibody clustering, independent of ...

TNF Pharmaceuticals, Inc. ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, and Renova Health ...

A newly identified subtype of Castleman disease will help diagnose and properly treat thousands of patients who have been ...

While we might think the gut serves a single, stinky function, it is, in fact, doing much more. The proper, healthy wo ...

The Cancer Biologics Market is witnessing remarkable growth fueled by an expanding therapeutic landscape and a burgeoning pipeline of innovative biologic therapies. Unlike traditional treatments, ...

Review highlights how vitamin D, particularly its active form calcitriol, modulates immune responses, inflammation, and tumor ...

This article follows part one of our two-part series, where we discussed how Philips designs innovation and digital health solutions for areas of India's healthcare system where options are sparse.